Health Tech Funding Surges as The Carevoice Raises $10M in Series B Round, Defying Industry Slowdown

• The Carevoice raises $10 million in Series B funding, defying the health tech funding slowdown
• Insurtech companies turning to “embedded insurance” model for success
• Investors emphasize good economics and healthy traction for startups in the insurance technology space
• The Carevoice secures funding from Apis Insurtech Fund I, bringing total capital raised to $20 million
• Company plans to expand partnerships with insurers globally and invest in enhancing CareVoiceOS

The CareVoice Secures $10 Million in Series B Funding

In the realm of health tech funding, where the landscape has been experiencing a slowdown, the recent success story of The CareVoice shines brightly. The company recently announced that it has secured $10 million in Series B funding, a significant achievement in an environment where venture investment has been on the decline. This funding round was led by the U.K.-based Apis Insurtech Fund I, with a majority of the round’s contribution coming from them. With this latest financing, The CareVoice has now raised a total of around $20 million, a testament to its appeal to investors in the health tech space.

Weathering the Storm of Funding Slowdown

The broader health tech industry has seen a funding slowdown in recent times, with U.S.-based digital health startups raising the lowest amount since 2019. This challenging environment also affected The CareVoice, although the company managed to navigate through it successfully by achieving healthy cash flow. Despite facing a setback when one of its investors became “valuation sensitive” and reduced the startup’s revenue multiple, the company adjusted its fundraising strategy and focused on becoming profitable. By mid-2022, The CareVoice had already secured funding commitments for its Series B, and through diligent efforts, it reached cash flow neutrality from Q3 2022 onwards.

Empowering Health Providers with Embedded Solutions

The CareVoice operates as an embedded insurance solution provider, offering innovative services that enhance the customer journey for both insurers and end-users. The company’s approach has resonated with investors and clients alike, as evidenced by its successful funding rounds and rapid revenue growth. The CareVoice’s ability to swiftly deploy health tech solutions sets it apart from traditional IT and consulting service providers, offering a more agile and cost-effective alternative for health providers looking to enhance their digital offerings.

Related Video

Published on: July 23, 2021 Description: What drives the costs of healthcare in the United States? Every year sees new and exciting innovations to treat rare diseases, but ...

Government Funding of Medical Innovations: High Tech or Low Tech?

Future Expansion and Innovation

Looking ahead, The CareVoice plans to utilize its fresh funding to expand its partnerships with insurers across various regions, including Asia, Europe, the Middle East, Africa, and the Americas. Additionally, the company aims to invest in further developing its proprietary operating system, CareVoiceOS, which serves as a foundational technology for its insurer clients. With a dedicated team of around 40 employees, The CareVoice is poised for growth and innovation in the dynamic landscape of health tech, continuing to drive positive change in the industry.